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The investigation of patterns of change in psychological
treatments has recently emerged as a topic in the research literature.
Most treatment concepts and protocols so far have the implicit
assumption of a linear or log-linear change course as the common
pattern for all patients (e.g., Howard, Kopta, Krause, & Orlinsky,
1986; Lambert, Hansen, & Finch, 2001). However, interindividual
differences in change over the course of the treatment might reflect
different mechanisms and processes of change (Kazdin, 2007).
Furthermore, knowledge about differences in change profiles might
enable researchers and clinicians to maximize treatment outcomes for
individual patients (Barlow, 2010; Lambert, 2007; Lutz, 2002).
Therefore, research on early change is not only related to the debate
on the optimal “dosage” of therapy. It is also an important issue
related to the growing interest in routine outcome monitoring and
practice-oriented research (Castonguay, Barkham, Lutz, & McAleavy,
2013; Lambert, 2013; Newnham & Page, 2010; Shimokawa, Lambert,
& Smart, 2010). However, to enable therapists to derive decisions
about patients’ improvement or nonimprovement from feedback
information, rules based on scientific considerations and empirical
tests are necessary.
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Different methods and criteria for the definition of such decision
rules have been proposed (e.g., Lambert et al., 2002; Lutz, Stulz,
Martinovich, Leon, & Saunders, 2009). These different concepts can be
broadly classified into two general classes: (a) those that take
information from two time point assessments into account and (b)
those that are able to consider information from the whole treatment
course.
Decision rules based on only two assessments are relatively
simple comparisons between impairment scores on a certain
instrument for two time points. These rules define how large the
difference between these scores has to be to consider that change
improvement or deterioration. These definitions could, for example,
rely on a priori–defined expert judgments about good and poor
treatment progress. Regularly, these judgments rely on the
psychometric properties of an instrument in different reference
samples. These properties guide the decision on how much change
must have been achieved, given a certain intake score, to consider a
treatment successful, unhelpful, or even harmful. An often-applied
method of this kind is the concept of clinically significant change
introduced by Jacobson, Follette, and Revenstorf (1984) and extended
Jacobson and Truax (1991). In this approach, to be considered
clinically significantly improved from Time Point 1 to Time Point 2,
patients’ scores on an instrument have to meet two criteria: (a) the
scores have to move from a range that is more probable for a sample
of clinically impaired patients into a range that is more probable for a
nonclinical reference sample, and (b) the difference between the
scores has to be statistically significant and, thus, not just a result of
imprecise measurements. If only the second criterion is met, an
observed improvement is evaluated as reliable (i.e., statistically
significantly different from zero) but not clinically significant, because
the impairment score after the treatment is still highly probable for
impaired reference samples. This concept of clinically significant
change has great appeal to practitioners, because it can easily be
applied in everyday clinical practice.
In comparison, decision rules taking into account the entirety of
change course information are, for example, based on statistically
derived response predictions based on repeated assessments of
already treated patients. With the growing availability of large datasets
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including repeated measurements over the course of treatment and
the growing capacity of computers, sophisticated approaches based on
intensive longitudinal methods have been more often developed.
Modern statistical tools of growth curve modeling have been applied to
generate expected treatment response (ETR) curves. These predictions
can be compared with the actual change course of a patient (e.g.,
Finch, Lambert, & Schaalje, 2001; Lutz et al., 2005). On this basis,
treatment response patterns can be detected. Specifically, growth
mixture modeling (GMM) has been demonstrated to be useful for the
identification of early change patterns (e.g., Cuijpers, van Lier, van
Straten, & Donker, 2005; Lutz et al., 2014; Rubel, Lutz, & Schulte,
2013; Stulz, Lutz, Leach, Lucock, & Barkham, 2007). GMM is a latent
variable cluster analytic method. This method allows the categorization
of patients into classes with shared treatment response over a defined
time period (Nagin & Odgers, 2010).
Both of the just-described methods have been used to identify
early change patterns, support therapists in the evaluation of their
patients’ treatment progress, and guide them to adapt their treatment
planning accordingly (e.g., Lutz, Böhnke, Köck, 2011).
Several studies have identified subgroups of clients showing
substantial improvements early in treatment. Most of these studies
suggest that these fast-responding patients are able to maintain their
initial success in that they show markedly positive outcomes (e.g.,
Haas, Hill, Lambert & Morrell, 2002; Lutz et al., 2014; Lutz, Stulz, &
Köck, 2009). Despite the observation of early positively responding
patients in different studies, there is no consistent definition of the
phenomenon of “early positive response.” For example, Stewart et al.
(1998) operationalized it as psychopathology being absent or minimal
after 2 weeks of treatment. Other studies used a minimum percentage
of improvement in the relevant outcome measure to identify early
positively responding patients (Hayes et al., 2007; Renaud et al.,
1998). Again, others used ETR curves to define early positive change
by comparing these predictions with the actual session-to-session
ratings of patients’ symptomatology (Haas et al., 2002; Leon, Kopta,
Howard, & Lutz, 1999). In summary, definitions of early positive
response have been dependent on the researchers’ divergent
judgments on the essential aspects of this construct.
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Recently, GMM has been repeatedly used for the investigation of
patterns of early change in psychotherapy, and it has consistently
revealed a pattern of early improving patients (e.g., Lutz et al., 2014).
However, GMM is a rather complex statistical method with
computationally demanding model-estimating algorithms. Given that,
an important question not yet answered is whether GMM-identified
early positive responders are a more informative subgroup than those
identified with less complex change evaluations (e.g., clinically
significant change). The aim of this study was to compare the concept
of clinically significant change (Jacobson & Truax, 1991) with a GMMbased approach regarding their shared and distinct characteristics for
the identification of early positive treatment response. Consequently,
the following research questions were addressed in this study: First,
how are the differentially identified early positive response groups
related to each other regarding the following variables?: number of
patients identified, overlap of subgroups, intake impairment, therapy
outcome, and therapy length. Second, how stable are the differentially
identified early improvements in the course of the treatment? Third, is
the more complex GMM approach more advantageous than simple
clinically significant change criteria in terms of specificity and
sensitivity for the detection of early positive responders who also show
positive treatment outcomes?

Method
Patients
The complete study sample consisted of 5,484 patients treated
between June 2006 and December 2011 for at least four sessions in 26
centers comprising 20 college counseling centers, four primary care
medical centers, and two private mental health centers. A written
informed consent to allow for the anonymous use of their data in
research projects was given by clients prior to their first assessment.
Patients were treated for different psychological problems,
predominantly symptoms of depression and anxiety. The majority of
patients were female (61.7%; 3.6% did not report), and all of them
were 18 years of age or older. Most of the patients who gave
information about their racial background described themselves as
European American (40.7%). The further distribution of patients’
Psychological Assessment, Vol 27, No. 2 (June 2015): pg. 478-488. DOI. This article is © American Psychological
Association and permission has been granted for this version to appear in e-Publications@Marquette. American
Psychological Association does not grant permission for this article to be further copied/distributed or hosted elsewhere
without the express permission from American Psychological Association.

5

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

ethnicity was as follows: Asian American (4.1%), African American
(3.7%), Latino/Hispanic (3%), Native American (0.5%), multiracial
(0.4%), and other (7.9%; 39.7% did not report). Regarding
relationship status, 41.7% indicated that they were single, 16.7%
dating, 7.5% married, 1.5% separated, and 0.7% divorced (31.9% did
not report).
Most of the patients (3,894; 71%) started treatment with global
mental health (GMH) scores in the range of a clinically impaired
reference sample with regard to the cutoff criterion c described by
Jacobson et al. (1984) and Jacobson and Truax (1991).

Therapists and Treatment
Two hundred and forty therapists from different professional
backgrounds (including psychologists, psychiatrists, clinical social
workers, and trainees) provided the treatments. Therapists were
predominantly female (65.8%; 8% did not report) and European
American (64.6%; 18.3% did not report). Regarding degrees, most of
the therapists had a master’s (46.7%) or a doctorate (29.2%; 8.8%
did not report). There was no requirement for therapists to follow a
manualized treatment protocol. Treatment duration was not fixed to a
strict time limit and varied between four and 109 sessions (M = 9.76,
SD = 8.25, Mdn = 7.00).

Measures
Prior to each session, the Behavioral Health Measure–20 (BHM20; Kopta & Lowry, 2002) was administered via a computer-based
system, the CelestHealth System-MH (Bryan, Kopta, & Lowes, 2012).
The BHM-20 is a 20-item self-report measure consisting of three scales
that cover the proposed phases of psychotherapy outcome (Howard,
Lueger, Maling, & Martinovich, 1993): well-being (three items),
symptoms (13 items), and life functioning (four items). Respondents
are asked to rate the items regarding how they have been feeling over
the past 2 weeks on a Likert-type scale ranging from 0 (extreme
distress/poor functioning) to 4 (no distress/excellent functioning). A
GMH score is calculated by adding the scores for all 20 items and
dividing this sum by the number of endorsed items. High scores in the
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GMH indicate good psychological functioning. The internal consistency
reported for GMH in a larger sample from which the present study
sample is a subsample was reported as α = .91 (Stulz, Lutz, Kopta,
Minami, & Saunders, 2013). A test–retest reliability for a 2-week
interval between tests in a college student sample was reported as rtt
= .80. With regard to discriminant validity, the instrument showed the
ability to distinguish clinical from nonclinical groups. Concurrent
validity was shown by high correlations between the GMH scale and
other established measures, including the Outcome Questionnaire–45
(Lambert & Finch, 1999) and the Symptom Checklist–R–90 (Derogatis
& Savitz, 1999), with rs = −.81 and −.85, respectively.

Data Analysis
Early positive response. As described earlier, the definition of
early positive response varies considerably between studies. Besides
the applied methods, the time criterion is also subject to this variation.
As a consequence, there is no agreed upon time span that is
universally defined as “early” in psychotherapy research. For the
present study, we chose the time criterion taking into account clinical
and methodological considerations. Obviously, clinicians need to take
decisions right from the start of the treatment and continuously
throughout its course. It has been repeatedly shown that decisions
based on statistical predictions are at least equal to and often better
than decisions based solely on clinical judgment (e.g., Grove, Zald,
Lebow, Snitz, & Nelson, 2000; Meehl, 1954). Thus, from a clinical
perspective, it is important to design decision rules that support
clinicians in their decision-making process as early in the treatment as
possible.
Methodologically however, GMM as a latent growth model needs
at least three scores to model a log-linear trend that was repeatedly
reported for individual change curves in the research literature (e.g.,
Stulz et al., 2013). Consequently, we decided to define the time span
until the third assessment (session) as “early.” This is the earliest time
point that allows for modeling of a log-linear change trend. Application
of this rationale resulted in a time criterion that was the same as the
one chosen by Haas et al. (2002).
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GMM. First, the assumption of a log-linear relationship between
the amount of treatment and outcome was tested comparing an
intercept-only, a linear, and a log-linear latent growth model. A loglinear (i.e., a negatively accelerated) association between number of
sessions and change corresponds to the assumptions of the doseresponse model (Howard et al., 1986), which is widely used in
psychotherapy research (Kopta & Lowry, 2002). In the next step,
typical patterns of early change in the GMH scores over the first three
sessions were identified using GMM. This method enables the
identification of unobserved groups of individuals with shared patterns
of change over time in one or more outcome variables (Muthén,
2004). It is based on conventional latent growth models (LGMs) but
relaxes (i.e., does not adhere to) the assumption that all individuals in
a sample need to be drawn from a single population. Instead, by
implementing a categorical latent variable into the LGM framework,
GMM allows the identification of subpopulations (latent classes) of
individuals that correspond to different shapes of growth curves. In
GMM, the mean growth curves for each latent class as well as the
individual variations around these growth curves in terms of growth
factor variances are estimated. In this current application, a model
was chosen for which variances around the class-specific slopes were
fixed to zero within classes, whereas intercept variances were freely
estimated but constrained to be constant between classes.
Consequently, all differences in change over time had to be captured
completely by the differences in mean slopes of different latent
classes. This model was stable and emphasized the identification of
heterogeneity in change over time.
In this study, GMMs were estimated using the Mplus software
(Version 6.0; Muthén & Muthén, 2010). Mplus uses maximum
likelihood estimates as well as an accelerated expectation
maximization procedure and allows for the estimation of models with
missing values in continuous outcome variables.
Prior research applying GMM to session-by-session
psychotherapy data has repeatedly identified a subgroup of patients
who start treatment highly impaired and improve in the first few
sessions. Patients showing such a pattern are, in the following,
referred to as GMM—early positive change.
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Clinically significant change criteria. Patient change was
additionally assessed using the concept of clinically significant change
(Jacobson & Truax, 1991). This concept is composed of two conditions.
The first condition to consider the change of a patient clinically
significant is reliable improvement. A patient changed reliably (i.e.,
statistically significantly; p < .05) if the difference between the two
scores is larger than the reliable change index (RCI) of the instrument.
The second condition is the movement of the scores from the range
that is more likely for a clinical reference sample into the range that is
more likely for a nonclinical reference sample (crossed cutoff). For the
comparison with the GMM-based approach, reliable improvement and
clinically significant improvement are investigated as two separate
methods. On the basis of their GMH scores from the first to the third
session, patients were categorized in one of two groups: (a) clinically
significant improvement, with the GMH score moving from a score
below 2.92 (cutoff) before the first session to a score above 2.92
before the third session and the difference between these two scores
being larger than 0.39 points (RCI), or (b) reliable improvement, with
the difference between the first score and the third score being larger
than 0.39 points but the cutoff value of 2.92 not being crossed.
For the evaluation of treatment outcome, the difference
between the first and the last score is assessed using the same
criteria. Two additional groups for the description of negative
treatment outcomes were defined: (c) no change, with the difference
between the first score and the last score being smaller than 0.39
points and (d) deterioration, with the difference between the first score
and the last score being larger than 0.39 points but in the negative
direction.

Results
Reliable and Clinically Significant Improvement
At Session 3, 1,918 (35.0%) out of the 5,484 patients met the
criterion of reliable improvement. Eight hundred and ninety-two
patients (16.3%) had achieved clinically significant improvement until
Session 3, whereas 3,035 patients (55.3%) showed no statistically
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reliable change from the first to the third session, and 531 (9.7%) had
deteriorated until Session 3.

Early Change Patterns (GMM)
The Bayes information criterion (BIC; Schwartz, 1978) indicated
the best fit for a log-linear model: intercept-only Model 111,923.96,
linear Model 110,806.38, and log-linear Model 110,733.71.
Accordingly, the subsequent growth mixture analyses assumed a loglinear relationship between the number of treatment sessions and
outcome.
In the following analyses, the number of distinct patterns of
early change was determined by means of GMM (Muthén, 2004).
Starting with one latent class (i.e., with a conventional LGM),
additional classes were entered into the GMM until the optimal number
of latent classes was found. The decision on the number of latent
classes was based on joint consideration of two typically applied
indices. The BIC (Schwartz, 1978) steadily decreased from the onethrough the seven-class solutions (21,742.17; 21,532.58; 21,318.14;
21,220.09; 21,116.84; 21,069.74; and 21,052.47), indicating a model
with at least seven classes having the best fit. In comparison, the Lo–
Mendell–Rubin likelihood ratio test of model fit (Lo, Mendell, & Rubin,
2001) showed that already the addition of a fifth class did not result in
a significant improvement of model fit (three classes vs. four classes:
p < .01; four classes vs. five classes: p = .08). Consequently, a model
with four classes (see Figure 1) was considered the best solution and
used for further analyses.
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Figure 1. Estimated mean change trajectories over the first three sessions for a fourclass growth mixture model solution.

The first subgroup comprised of 396 patients (7.2%) who
started treatment with a relatively high average impairment (intake
GMH score: M = 1.80, SD = 0.41) and improved relatively quickly until
Session 3. Patients categorized in this group showed early positive
response according to the GMM approach and constitute the GMM—
early positive change group, as specified earlier. The second subgroup
comprised of 1,518 patients (27.7%) who also started treatment
relatively highly impaired (intake GMH score: M = 1.92, SD = 0.35)
but improved relatively slowly until the third session. Both of these
first two subgroups started treatment substantively more impaired
than an average patient from a counseling (M = 2.68) and outpatient
psychotherapy (M = 2.33) reference sample (Kopta & Lowry, 2002).
The third subgroup was by far the largest, comprising 3,440 patients
(62.7%). This class included patients who started with a relatively low
initial impairment (intake GMH score: M = 2.89, SD = 0.42) and
showed rather slow improvement until Session 3. The fourth subgroup
comprised of a small number of patients deteriorating during the first
three assessments (n = 130; 2.4%). The mean intake GMH score of
the fourth subgroup was 2.92 (SD = 0.43). Comparing the initial
impairment of Subgroups 3 and 4 with counseling and psychotherapy
reference samples reveals that these subgroups started with
comparatively low levels of impairment (Kopta & Lowry, 2002).
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Overlap Among the Three Definitions of Early Positive
Response
In a next step, the overlap and uniqueness of the differentially
identified early positive response groups were investigated. The overall
numbers and the overlap between the three groups, with percentages
given in reference to each overall number, are displayed in Table 1.

Numbers of Patients in the Differentially Identified Early Positive-Response Groups and
Their Overlaps at Session 3

Overall, the GMM approach identified many fewer patients as
early positive responders than did the reliable improvement (about five
times fewer) and clinically significant improvement (about two times
fewer) criteria. However, considering the different group sizes, the
three groups were largely overlapping (see Table 1). All patients in the
GMM—early positive change group also improved reliably from intake
to Session 3 (N = 396; 100%). Clinically significantly improved
patients were 253 (64%) of these GMM—early positive change
patients. Because of the overall group size differences, these numbers
correspond to only 21% of reliably improved patients who were also
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identified via the GMM approach and to 28% of clinically significantly
improved patients.

Relations to Treatment Length, Intake Impairment, and
Treatment Outcome
The three groups of early positively responding patients
identified via different methods were compared with regard to
treatment length, intake impairment, and treatment outcome. In
terms of number of sessions in treatment, the three groups did not
differ significantly (see Figure 2) from each other (GMM—early positive
change: M = 8.32, SE = 0.41; reliably improved: M = 8.93, SE =
0.37; clinically significantly improved: M = 8.57, SE = 0.44). With
regard to initial impairment, patients with early positive response
identified via GMM (M = 1.79, SE = 0.03) started with lower GMH
scores (indicating higher impairment) than early improving patients
identified with the two other methods (reliable improvement: M =
2.10, SE = 0.03; clinically significant improvement: M = 2.38, SE =
0.03). The GMM—early positive change group also showed by far the
highest pre- minus posttreatment differences (high values indicating
large positive changes from pretreatment to posttreatment) in GMH
scores (M = 1.28, SE = 0.03; reliably improved: M = 0.93, SE = 0.03;
clinically significant improved: M = 0.85, SE = 0.04).

Figure 2. Mean numbers of sessions, mean intake general mental health (GMH)
scores, mean differences between pre- and posttreatment GMH scores (high values
indicating high positive changes from pretreatment to posttreatment), and 95%
confidence intervals for each of the early positive response groups and the complete
sample.

A more fine-grained examination of the relations among
treatment outcome, early change, and therapy length is depicted in
Table 2, which shows, the pre–post effect sizes (ds) and categorized
change statuses after treatment (reliably improved, clinically
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significantly improved, no change, and deterioration) for the three
early positive change groups, depending on the number of sessions
attended and in total. Irrespective of the number of sessions attended,
the GMM—early positive change group showed the highest pre–post
effect sizes (ds = 1.88–2.16) as well as the highest shares of reliably
improved patients after the treatment (90%–93%). In comparison, the
groups of patients identified via clinically significant change methods
both showed smaller yet also high effects sizes (both between about
1.15 and 1.36) and shares of reliably improved patients at the end of
the treatment (both between 74% and 82%). Regarding clinically
significant change after the treatment, the GMM—early positive change
group and the group of patients who had improved clinically
significantly at Session 3 showed similar shares (both in the 65%–73%
range). In comparison, a little less of the early reliably improved group
achieved clinically significant change until the end of the treatment
(51%–53%). The numbers of patients who showed no change or
deterioration from pre- to post-treatment were slightly smaller in the
GMM—early positive change group than in the groups defined via
reliable and clinically significant change criteria.

Frequencies and Final Treatment Outcomes (ds and Categories) for All Patients and for
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Those Meeting the Respective Early Positive Response Criteria (Status After Session 3)
Depending on Treatment Length and in Total

Compared with the effect sizes for each of the three early
positive response groups, the average effect sizes for all patients in
the sample were consistently smaller (between 0.62 and 0.75). On
average, effect sizes for all patients were about half as high as those
of the groups defined with clinically significant change criteria and onethird as high as the GMM-defined group. Accordingly, although the
rates of reliably and clinically significantly improved patients at the end
of the treatment were much lower (between 28% and 35% and
between 12% and 18%, respectively) the rates of patients showing no
change or deterioration over the course of the treatment were much
higher (between 55% and 64% and between 9% and 11%,
respectively).
To evaluate the predictive power of the different approaches for
final treatment status, specificity and sensitivity values were
calculated, and these are presented in Table 3. Although the GMM—
early positive change group showed the highest specificities for
predicting positive reliable change (0.989) and clinically significant
change (0.964) from pre- to posttreatment, its sensitivities were the
lowest for both outcome criteria (.135 for reliable and .157 for
clinically significant improvement). Similarly, high specificity values for
the prediction of reliable and clinically significant improvement were
found for the early positive responders classified via clinically
significant change criteria (.933 for both reliable and clinically
significant improvement). Sensitivity values for this subgroup were
higher but still low (.260 for reliable and .386 for clinically significant
change). The highest sensitivity values were obtained for the reliable
early improvement criterion (.559 for reliable .599 for clinically
significant improvement). Conversely, specificity values were the
lowest for this subgroup of early positive responders identified via
reliable change (.856 for reliable and .757 for clinically significant
improvement).
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Specificity and Sensitivity Values of the Three Classification Methods for the Prediction
of Positive Reliable Change and Clinically Significant Change After Treatment

Stability of early improvements given the differential definition
methods is illustrated in Figure 3, which shows the percentages of
reliably improved patients after each of Sessions 4 through 13 and at
the end of the treatment. Independent of session number, the rate of
reliably improved patients was consistently highest in the GMM—early
positive change group (about 90%). Only slight fluctuations could be
observed over the course of the first 13 sessions. The rates for the two
early improving groups defined with the clinically significant change
criteria were similar to each other and consistently smaller than those
for the GMM-defined group.
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Figure 3. Percentages of reliably improved patients after Sessions 4–13 and after the
end of the treatment for 5-patient subgroups defined on the basis of their change
status after Session 3.

Discussion
In this study, three methods for the identification of early
positive response to psychotherapy were compared with regard to
overlap and uniqueness of the identified subgroups and their specific
characteristics and predictive qualities. A GMM-based approach was
compared with two methods from the concept of clinically significant
change. Given the methodological definitions of the clinically significant
change methods and GMM, there are some general differences, which
can be deduced on a theoretical basis: Whereas for the clinically
significant change methods, an a priori fixed amount of change is
minimally required to meet one of the criteria (RCI), GMM is more
flexible in this regard. How much change is needed to be identified by
the GMM approach depends on the nature of the change courses within
the whole patient sample and all of the available change course
information. GMM is also more flexible with regard to intake and end
state functioning. To be categorized as clinically significantly improved,
a patient’s score has to move from the range above an a priori defined
cutoff score into the range below that cutoff score. Consequently,
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patients who do not start the treatment within the range above the
cutoff score can never improve “clinically significantly.” As for the GMM
approach, there are no such cutoff scores. Given that, theoretically
every patient can be categorized as belonging to the improved group.
Another important difference is the fact that the GMM approach takes
into account the complete change course until a certain time point.
Clinically significant change criteria, conversely, solely rely on the
comparison of change from one time point to another.
The aim of this study was to compare these three methods for
the identification of early positive response to psychotherapy on an
empirical basis. For this purpose, these methods were applied to the
first three scores of patients in a big naturalistic outpatient
psychotherapy sample. The results of the comparison of the three
methods provide evidence that the different identification methods
have very specific characteristics when defining similar patients as
early positive responders. In fact, all of the early positive responders
identified via GMM were also detected by the reliable improvement
method. Given that, the GMM—early positive change group was a
subgroup of the patients reaching positive reliable change until Session
3. However, GMM categorized about five (positive reliable change) and
two (clinically significant change) times fewer patients as early positive
responders than did the other methods. Consequently, the GMM
approach is more conservative in its identification of early positively
changing patients than are clinically significant change methods.
Further, it could be shown that the GMM—early positive change
group was characterized by higher average intake impairments and
larger average pre- to posttreatment changes than the groups
identified via clinically significant change criteria. As high intake scores
are regularly connected to higher pre- to posttreatment changes,
these results suggest that the difference between the early positive
responders identified with the GMM approach and those defined via
reliable change until Session 3 was mainly attributable to high intake
values. As a consequence, one could argue that the GMM model is
unnecessary if the amount of change from intake to Session 3 and the
intake score are known. To test this hypothesis, a binomial logistic
regression analysis was conducted. Being classified as an early positive
responder with the GMM method (yes = 1, no = 0) was used as
categorical dependent variable; changing reliably positively until
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Session 3 (yes = 1, no = 0) and the pretreatment GMH score were
used as predictor variables in the regression analysis. Only 78 (19.7%)
of the 396 early change patients identified via GMM were correctly
predicted by the logistic regression model using these predictor
variables. Given that, GMM-identified early positive responders were
not just a subgroup of reliably improved patients with very low intake
scores (high intake impairment). Thus, the application of GMM for the
identification of early positively responding patients supplies additional
information that cannot be deduced alone from the intake score and
the amount of change until Session 3. This might be due to the fact
that GMM does not use only the information from two time points
(Session 1 and Session 3). Because GMM takes each of the repeated
assessments of individual change curves into account, this definition
generally requires a more stable positive response pattern than do the
clinically significant change criteria. There might be many patients
starting with high initial impairment and changing reliably or even
clinically significantly from the first to the third session but not
meeting the GMM criteria because the score in the second session was
not positive enough. This aspect is more pronounced the more
assessments that are considered. In the case of the present study, in
which only three assessments were taken into account also, rather
instable change courses could result in an average early response
pattern if the gain from the second to the third session was big
enough.
With respect to outcome prediction, which is the basis for the
formulation of decision rules, it could be shown that both the GMM
approach and the computationally less demanding clinically significant
change methods had their positive and negative aspects. Being
identified as an early positive responder by the GMM approach was a
highly reliable prognostic factor for being reliably improved after the
treatment. However, this method showed itself to be very insensitive.
As a consequence, many patients who improved reliably or clinically
significantly from pre- to posttreatment would have been missed if
only GMM had been applied.
Given their ease of use, it comes as somewhat of a surprise that
clinically significant change criteria showed such a good performance
in predicting ultimate treatment outcome. While being only slightly
less specific than GMM in the prediction of treatment success, the
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reliable improvement method in particular proved to be much more
sensitive than the more complex GMM approach.
Given that, decision rules should not solely rely on GMM. Rather
GMM-based approaches should be complemented by more sensitive
reliable and clinically significant change methods. In practice, such an
integrated approach could be implemented in feedback software tools
by the means of a stepwise system with different probability estimates
for positive outcomes depending on the method that classified a
patient as an early positive responder.
However, one of the limitations of the present study concerns
the results of the comparison of the methods regarding their predictive
qualities for treatment outcome. One of the three compared methods
is also used to assess treatment outcome. We chose the clinically
significant change criteria for the evaluation of treatment outcome
(see Tables 2 and 3) because they are widely used methods in clinical
research and practice (cf. Ronk, Korman, Hooke, & Page, 2013). It
should be noted that the predictive power of a method is regularly
relatively high if it is used to define a state at two time points and the
latter state is predicted from the first state. Compared with that, the
predictive power is lower when two different methods are used to
define the states at the two respective time points. Accordingly,
because the reliable and clinically significant change criteria are more
similar to each other than to the GMM approach, the present results
might be biased to the disadvantage of GMM. Future investigations
should consider evaluating the different methods by using a different
instrument for the evaluation of treatment outcome than the one used
here for the assessment of early positive change.
In addition, the generalizability of these results is reduced
because only patients with at least four sessions were included in the
analysis. Given that, the present results are only valid for patients who
do not drop out before the fourth session. However, previous studies
have shown that some patients experience substantial improvements
in the first or first two sessions (Haas et al., 2002). Thus, there might
be some early improving patients who were excluded from the current
analysis because of a too early termination of the treatment.
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Another shortcoming of the present study regards the definition
of early, which is always a matter of debate and is related to
theoretical orientations, national health care policies, and the actual
number of sessions attended by each individual patient. It follows from
that that, for patients being provided with 300 sessions of therapy, the
early phase might rather be the first 30 sessions instead of the first
three. But for patients who were provided with four sessions, the first
three also cannot be doubtlessly defined as “early.” Owing to these
considerable differences, it simply would not be possible to define an
early treatment phase that would be appropriate from all perspectives.
Consequently, this definition has to be done on grounds of the specific
characteristics of the investigated patient sample. In the current
investigation, we decided to define as early the shortest possible time
span that still enabled us to estimate a log-linear change trend with
the GMM approach. Although Haas et al. (2002) chose the same
interval, compared with most other investigations of early response,
the first three assessments represents a rather short phase. In
addition to the just-stated rationale, several other reasons support our
decision to reduce the time span to this minimum. First, the
treatments in this sample were rather short (M = 9.76 sessions). Thus,
our early phase definition already covered, on average, about onethird of the complete treatment. In addition, the number of patients
that could be taken into account was at its maximum when the
required number of sessions was minimal. Thus, this approach enabled
us to derive predictions for about 20% more patients than we could
have if we had extended the early phase to Session 4 and 34% more
patients than we could have if we had extended the early phase to
Session 5. However, utility for clinical practice was the most important
argument for choosing the shortest possible phase. Decision rules are
designed to assist clinicians in their decision making. Therefore, it
should be the aim of researchers to design decision rules so that they
can be validly applied as early in treatment as possible.
It must also be admitted that a potential alternative explanation
of early positive response in psychotherapy outcome studies is
regression to the mean. Statistically, patients who start treatment
rather highly impaired have more room to improve in their scores than
do patients who start with relatively low impairment. For the present
sample, this is also reflected in the significant negative correlation
between the initial score and the change score from pre- to
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posttreatment (r = −.53, p = <.00). In such cases, when the
correlation between initial scores and amount of change is negative,
the occurrence of regression to the mean is likely (Rogosa, Brandt, &
Zimowski, 1982; Speer, 1992). The common clinically significant
change concept introduced by Jacobson and Truax (1991), which was
applied in the current study, does not take regression to the mean into
account. Speer revisited the concept and presented a method that
considers regression to the mean as being more conservative for more
impaired patients (more distant from the mean). Therefore, all early
change classes were additionally checked with this more conservative
method proposed by Speer. All of the patients who were defined as
early positive responder by the Jacobson and Truax method or by the
GMM method also improved statistically significant (p < .05) according
to the Speer method. Thus, it is unlikely that regression to the mean
was the only factor that led to early positive improvements.
Despite these limitations, the current study may have potential
implications for future research, health care services, and clinical
practice. Considering the results of the current study, future research
on early response might be better able to anticipate the implications
connected with the different methods. For the evaluation of
correlations between early response and treatment outcome, it is of
central importance to know which methods were applied for the
definition of early positive response and how specific and sensitive
they are. However, replications in other samples, settings, and
countries as well as with different instruments are needed to validate
and generalize our results. Given the high rates of patients from the
early positive response groups who showed positive ultimate
treatment outcomes, psychometric progress monitoring and feedback
seem to be important tools for health services to optimize the
allocation of resources (i.e., treatment sessions). Patients who show
positive response at such an early stage of the treatment might need
fewer sessions than patients who need longer to show positive
response (cf. Lambert, 2007). However, to deduce concrete
suggestions for health care services, controlled clinical trials with
follow-up assessments would be necessary to test the hypothesis that
patients who improve early need fewer sessions to achieve stable
positive outcomes than do more slowly improving patients. Regarding
the design of feedback software systems, results suggest a
combination of the different approaches. Whereas early positive
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responders identified via clinically significant change criteria had very
high chances of a good treatment outcome, additional GMM-based
information could supply additional assurance to therapists.
An important message for practitioners who will not or cannot
use sophisticated feedback software is the very good performance of
the clinically significant change criteria for the prediction of ultimate
treatment outcome. Given the high predictive qualities of these easyto-apply methods, the RCI and the cutoff score of an instrument
should be mandatory information in every test handbook. Being
provided with this information enables every therapist who tracks his
or her patients’ progress session by session to evaluate the chances
for positive treatment outcome. Using the instrument from the present
study in a similar sample, a therapist could also directly apply the
findings from the present study. Therapists know, for example, that if
one of their patients improves reliably until Session 3, the probability
for this patient to be reliably or clinically significantly improved at the
end of the treatment is more than doubled (from 33.6% to 79.1% for
reliable and from 18.5% to 51.4% for clinically significant change).
Taken together, the findings of the present study illustrate the
specific characteristics of three widely used approaches for the
identification of early positive response in a large sample of
psychotherapy outpatients. The findings underline not only the
additional value provided by the computationally demanding GMM
approach but also the surprisingly good validity of predictions that can
be deduced on the grounds of simple clinically significant change
criteria. For routine outcome monitoring and feedback systems, the
results suggest that a combination of decision rules, a GMM-based
approach, and clinically significant change methods might be a fruitful
combination.

Footnotes
Criterion c defines the cutoff point as the point that lies halfway
between the mean of a functional and a dysfunctional population if
variances are equal. Considering the means and standard deviations
reported for the GMH score of the Behavioral Health Measure–20 in
Kopta and Lowry (2002), cutoffGMH is calculated as follows (Jacobson
et al., 1984; Jacobson & Truax, 1991):
1
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where M0/s0 and M1/s1 are the mean/standard deviations of a
community adult reference sample and a sample of psychotherapy
outpatients, respectively. This criterion resulted in a cutoffGMH score
of 2.92. Thus, patients with a GMH score below 2.92 are more likely (p
< .05) to belong to a clinical population than to a nonclinical
population.
2

The RCI is calculated using the following formula (Jacobson & Truax,

1991):
where SD is the standard
deviation of the GMH score in a community adult sample (Kopta &
Lowry, 2002), and r is the reliability (internal consistency; α = .91) of
the instrument in a similar sample (Stulz et al., 2013). Internal
consistency, instead of test–retest reliability, is used to calculate the
RCI. Internal consistency has been recommended for clinical samples
because test–retest reliabilities are likely to be deflated by real
individual differences in treatment response and phenomena like
spontaneous remission (Martinovich, Saunders, & Howard, 1996).
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